Oct. 1, 2012
Life Technologies Corporation
(NASDAQ: LIFE) has appointed
as senior vice president of the newly created External Affairs & Corporate Communications organization. In her new role, Cox will spearhead the company's global strategies that drive awareness of Life's major initiatives and uphold its solid corporate reputation across multiple stakeholder groups, including shareholders, media reporters, government officials and customers.
Cox has served as vice president of Investor Relations since
when she joined Life Technologies after more than 20 years of experience at other leading corporations in the medical device and pharmaceutical fields. As the primary contact for 24 Wall Street analysts and shareholders, she has developed successful global programs and strategies to promote the company to security analysts, institutional investors and individual shareholders.
"Carol has demonstrated strong leadership in her ability to drive new strategies that have greatly enhanced our investor relations program," said
Gregory T. Lucier
, Chairman and Chief Executive Officer of Life Technologies. "In this newly created role, Carol will be responsible for aligning our communications to all of our key stakeholders. Her wealth of executive experience in the investor relations, corporate communications and government relations fields is ideal to drive our messaging in a well-coordinated manner."
Prior to joining Life Technologies, Cox served as vice president of Investor Relations at CareFusion Corporation, where she established and developed the division following the 2009 spinoff from Cardinal Health. She also served as senior vice president of Global Corporate Communications and Investor Relations at Barr Pharmaceuticals for 13 years, where her team received several awards from
magazine for outstanding performance. Cox holds a bachelor's of arts degree in International Relations from the
University of Virginia
About Life Technologies
Life Technologies Corporation
) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum with more than 50,000 products for agricultural biotechnology, translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, GIBCO®, Ambion®, Molecular Probes®, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of
in 2011. Visit us at our website:
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Contact
SOURCE Life Technologies Corporation